NEW YORK (GenomeWeb News) – Affymetrix has named Andrew Last to be company chief operation officer and David Weber as chief commercial officer, the company said in a US Securities and Exchange Commission filing this week.

Last previously was executive VP of the firm's Genetic Analysis business unit, and Weber formerly was executive VP of global commercial operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.